Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06HPP
|
|||
| Former ID |
DIB001230
|
|||
| Drug Name |
AGT-182
|
|||
| Synonyms |
HIRMAb-IDUS; Iduronidase/human insulin receptor-targeting chimeric mAb fusion protein (imucopolysaccharidosis type II), ArmaGen
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Hunter syndrome [ICD-11: 5C56.31; ICD-10: E76.1] | Phase 1 | [1] | |
| Company |
ArmaGen Technologies Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1800). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.